Plasma B-type natriuretic peptides in children with cardiovascular diseases

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Natriuretic peptides (NP) are released from the heart in response to pressure and volume overload. The biologic properties of NPs include counterregulation of the rennin-angiotensin-aldosterone pathway and a decrease in sympathetic tone resulting in diuresis, natriuresis, and vasodilation. Natriuretic peptides help to maintain fluid balance and blood pressure in a healthy physiologic range. The B-type natriuretic peptide (BNP) and its N-terminal precursor (NTpBNP) have become important diagnostic biomarkers of cardiovascular diseases (CVDs) in adults. Although many studies suggest that BNP also is a reliable test for diagnosing significant CVDs in children, data are lacking on whether additional use of BNP increases diagnostic accuracy and predicts prognosis. This comprehensive review describes the utility of BNP and NTpBNP for various CVDs of the neonatal and pediatric age groups. Because BNP is not a stand-alone test, it should not replace history, physical examination, or clinical judgment, but it has a clear value in adding details to the whole story for children, thus enabling the front-line physicians to make a diagnosis, especially in the acute care setting.

Original languageEnglish (US)
Pages (from-to)1135-1145
Number of pages11
JournalPediatric Cardiology
Volume31
Issue number8
DOIs
StatePublished - Nov 2010

Fingerprint

Brain Natriuretic Peptide
Cardiovascular Diseases
Natriuretic Peptides
Chymosin
Natriuresis
Water-Electrolyte Balance
Diuresis
Angiotensins
Aldosterone
Vasodilation
Physical Examination
Age Groups
Biomarkers
History
Pediatrics
Blood Pressure
Physicians
Pressure

Keywords

  • BNP
  • Cardiovascular diseases in children
  • Natriuretic peptides
  • NTpBNP

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Plasma B-type natriuretic peptides in children with cardiovascular diseases. / Das, Bibhuti B.

In: Pediatric Cardiology, Vol. 31, No. 8, 11.2010, p. 1135-1145.

Research output: Contribution to journalArticle

@article{9096f87fd3ae449786d62cff6c750495,
title = "Plasma B-type natriuretic peptides in children with cardiovascular diseases",
abstract = "Natriuretic peptides (NP) are released from the heart in response to pressure and volume overload. The biologic properties of NPs include counterregulation of the rennin-angiotensin-aldosterone pathway and a decrease in sympathetic tone resulting in diuresis, natriuresis, and vasodilation. Natriuretic peptides help to maintain fluid balance and blood pressure in a healthy physiologic range. The B-type natriuretic peptide (BNP) and its N-terminal precursor (NTpBNP) have become important diagnostic biomarkers of cardiovascular diseases (CVDs) in adults. Although many studies suggest that BNP also is a reliable test for diagnosing significant CVDs in children, data are lacking on whether additional use of BNP increases diagnostic accuracy and predicts prognosis. This comprehensive review describes the utility of BNP and NTpBNP for various CVDs of the neonatal and pediatric age groups. Because BNP is not a stand-alone test, it should not replace history, physical examination, or clinical judgment, but it has a clear value in adding details to the whole story for children, thus enabling the front-line physicians to make a diagnosis, especially in the acute care setting.",
keywords = "BNP, Cardiovascular diseases in children, Natriuretic peptides, NTpBNP",
author = "Das, {Bibhuti B.}",
year = "2010",
month = "11",
doi = "10.1007/s00246-010-9758-x",
language = "English (US)",
volume = "31",
pages = "1135--1145",
journal = "Pediatric Cardiology",
issn = "0172-0643",
publisher = "Springer New York",
number = "8",

}

TY - JOUR

T1 - Plasma B-type natriuretic peptides in children with cardiovascular diseases

AU - Das, Bibhuti B.

PY - 2010/11

Y1 - 2010/11

N2 - Natriuretic peptides (NP) are released from the heart in response to pressure and volume overload. The biologic properties of NPs include counterregulation of the rennin-angiotensin-aldosterone pathway and a decrease in sympathetic tone resulting in diuresis, natriuresis, and vasodilation. Natriuretic peptides help to maintain fluid balance and blood pressure in a healthy physiologic range. The B-type natriuretic peptide (BNP) and its N-terminal precursor (NTpBNP) have become important diagnostic biomarkers of cardiovascular diseases (CVDs) in adults. Although many studies suggest that BNP also is a reliable test for diagnosing significant CVDs in children, data are lacking on whether additional use of BNP increases diagnostic accuracy and predicts prognosis. This comprehensive review describes the utility of BNP and NTpBNP for various CVDs of the neonatal and pediatric age groups. Because BNP is not a stand-alone test, it should not replace history, physical examination, or clinical judgment, but it has a clear value in adding details to the whole story for children, thus enabling the front-line physicians to make a diagnosis, especially in the acute care setting.

AB - Natriuretic peptides (NP) are released from the heart in response to pressure and volume overload. The biologic properties of NPs include counterregulation of the rennin-angiotensin-aldosterone pathway and a decrease in sympathetic tone resulting in diuresis, natriuresis, and vasodilation. Natriuretic peptides help to maintain fluid balance and blood pressure in a healthy physiologic range. The B-type natriuretic peptide (BNP) and its N-terminal precursor (NTpBNP) have become important diagnostic biomarkers of cardiovascular diseases (CVDs) in adults. Although many studies suggest that BNP also is a reliable test for diagnosing significant CVDs in children, data are lacking on whether additional use of BNP increases diagnostic accuracy and predicts prognosis. This comprehensive review describes the utility of BNP and NTpBNP for various CVDs of the neonatal and pediatric age groups. Because BNP is not a stand-alone test, it should not replace history, physical examination, or clinical judgment, but it has a clear value in adding details to the whole story for children, thus enabling the front-line physicians to make a diagnosis, especially in the acute care setting.

KW - BNP

KW - Cardiovascular diseases in children

KW - Natriuretic peptides

KW - NTpBNP

UR - http://www.scopus.com/inward/record.url?scp=78449290842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78449290842&partnerID=8YFLogxK

U2 - 10.1007/s00246-010-9758-x

DO - 10.1007/s00246-010-9758-x

M3 - Article

C2 - 20927510

AN - SCOPUS:78449290842

VL - 31

SP - 1135

EP - 1145

JO - Pediatric Cardiology

JF - Pediatric Cardiology

SN - 0172-0643

IS - 8

ER -